Sanofi India share news, announcements and annual reports
NSE: SANOFIBSE: 500674Pharmaceuticals & BiotechnologySmall Cap
Sanofi India Limited · Formerly Aventis Pharma · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1984 on BSE, May 2003 on NSE
Last close ₹3,204.10up ₹14.60 (0.46%)BSE ₹3,204.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,189.50.
30 Oct: open ₹3,265.00, high ₹3,422.60, low ₹3,175.10
52-week range of traded prices to 30 Oct 2026
₹2,758.20Low, 23 Oct 2026₹4,834.00High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,379 Cr614th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.84%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 45.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 57.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Jun 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,04,44220.0% delivered
Sanofi India board meetings
108 filed, newest first. Page 2 of 3.
Feb 2019
26 Feb · Board meeting
Oct 2018
31 Oct · Board meeting
16 Oct · Board meeting
Jul 2018
25 Jul · Board meeting
May 2018
8 May · Board meeting
Apr 2018
23 Apr · Board meeting
Feb 2018
22 Feb · Board meeting
Oct 2017
31 Oct · Board meeting
Jul 2017
Apr 2017
Feb 2017
Oct 2016
21 Oct · Board meeting
Jul 2016
Jun 2016
2 Jun · Board meeting
Apr 2016
Mar 2016
23 Mar · Board meeting
Jan 2016
Oct 2015
Jul 2015
Jan 2015
23 Jan · Board meeting
For approving the audited Accounts for the year ended December 31, 2014 and also to consider recommendation of final dividend for the said financial year.
Oct 2014
14 Oct · Board meeting
For approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2014.
Jul 2014
10 Jul · Board meeting
For:- (a) Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2014; and (b) Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2014.
Apr 2014
2 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2014 (which is the first quarter of the Company's financial year).
Feb 2014
11 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2013 and also to consider recommendation of final Dividend for the said financial year.
Oct 2013
15 Oct · Board meeting
Approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2013.
Jul 2013
10 Jul · Board meeting
For:- (a) Approving the Unaudited Financial Results for the quarter and half year ended 30th June 2013; and (b) Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2013.
Apr 2013
9 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2013 (which is the first quarter of the Company's financial year).
Feb 2013
8 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2012 and also to consider recommendation of final Dividend for the said financial year.
Oct 2012
15 Oct · Board meeting
For approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2012.
Jul 2012
5 Jul · Board meeting
For (1) Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2012, and (2) Considering the question of declaring an Interim Dividend for the current financial year ending December 31, 2012.
Apr 2012
16 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2012 (which is the first quarter of the Company's financial year).
Feb 2012
9 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2011 and also to consider recommendation of final Dividend for the said financial year.
Oct 2011
31 Oct · Board meeting
For approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2011.
Jul 2011
14 Jul · Board meeting
For (1) Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2011, and (2) Considering the question of declaring an interim dividend for the current financial year ending December 31, 2011.
Apr 2011
7 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2011 (which is the first quarter of the Company's financial year).
Feb 2011
2 Feb · Board meeting
For approving the Audited Accounts for the year ended December 31, 2010 and also to consider recommendation of Final Dividend for the said financial year.
Oct 2010
12 Oct · Board meeting
For approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2010.
Jul 2010
7 Jul · Board meeting
For : a) Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2010 and b) Considering the question of declaring an Interim dividend for the current financial year ending on December 31, 2010.
Apr 2010
8 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2010 (which is the first quarter of the Company's financial year).
Feb 2010
11 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2009 and also to consider recommendation of Final Dividend for the said financial year.
Oct 2009
14 Oct · Board meeting
For approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2009.
Jul 2009
9 Jul · Board meeting
For : a) Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2009 and b) Considering the question of declaring an Interim dividend for the current financial year ending on December 31, 2009.
Apr 2009
15 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2009 (which is the first quarter of the Company's financial year).
Feb 2009
6 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2008 and also to consider recommendation of Final Dividend for the said financial year.
Oct 2008
7 Oct · Board meeting
For approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2008.
Jul 2008
14 Jul · Board meeting
For approval of the Unaudited Financial Results for the quarter and half year ended June 30, 2008, the Board of Directors will also consider the question of declaring an Interim dividend for the current financial year ending on December 31, 2008. In case Interim Dividend is declared by the Board at the said Meeting, the Record Date for the purpose of payment of such Interim Dividend will be July 30, 2008.